OpEdNews - Page 3 of Article: Aspartame and FDA: Annotated Bibliography, As Requested by Hawaii Senate

Whereas, methanol is a severe metabolic poison classified as a narcotic that converts to formaldehyde and formic acid, and can embalm living tissue and damage DNA; and

METHANOL, A SEVERE METABOLIC POISON CLASSIFIED AS A NARCOTIC: LOUIS, R. J. SAX'S DANGEROUS PROPERTIES OF INDUSTRIAL MATERIALS, EIGHTH EDITION, NEW YORK: VAN NOSTRAND REINHOLD (1992) PP. 2251-2252.

THE TROCHO STUDY PROVES THE FORMALDEHYDE EMBALMS LIVING TISSUE AND DAMAGES DNA.
http://www.mpwhi.com/formaldehyde_from_aspartame.pdf

THE MEDICAL TEXT ASPARTAME DISEASE; AN IGNORED
EPIDEMIC, H. J. ROBERTS, M.D.,
www.sunsentpress.com DISCUSSES METHANOL
CONVERTING TO FORMALDEHYDE AND FORMIC ACID.
__________________________________________
Whereas, aspartame metabolites include formaldehyde, a class A carcinogen, diketopiperazine, a brain tumor agent, and formic acid, and

FORMALDEHYDE, A CLASS A CARCINOGEN:
www.mpwhi.com/formaldehyde_from_aspartame_press_release.pdf BY DR. WOODROW MONTE. HE ALSO WROTE ASPARTAME; METHANOL AND THE PUBLIC HEALTH, A PEER REVIEWED JOURNAL ARTICLE:
http://www.dorway.com/monte84.html

HERE IS THE SECRET TRADE INFORMATION SUBMITTED IN CONGRESSIONAL HEARINGS. IT READS LIKE PSYCHOMANIPULATION TO GET ASPARTAME APPROVED. IN THE LAST PARAGRAPH THEY ADMIT TO ALMOST COMPLETE CONVERSION OF DKP, THE BRAIN TUMOR AGENT, AND DON'T WANT THE FDA TO KNOW.
http://dorway.com/dorwblog/?page_id=48

DIKETOPIPERAZINE IS DISCUSSED IN DETAIL IN ASPARTAME DISEASE; AN IGNORED EPIDEMIC,
www.sunsentpress.com
BY H. J. ROBERTS, M.D.

ALSO IN EXCITOTOXINS; THE TASTE THAT KILLS BY NEUROSURGEON RUSSELL BLAYLOCK, MD, PAGE 212, www.russellblaylockmd.com
__________________________________________

Whereas, in 1974, the United States Food and Drug Administration approved aspartame as an artificial sweetener, but asked its manufacturer Searle to hold back from selling it on the market until further tests could be made with regards to its safety; and

ECOLOGIST AS REFERENCED ABOVE. ALSO THE BOOK RUMSFELD, HIS RISE, FALL AND CATASTROPHIC LEGACY, BY ANDREW COCKBURN, CHAPTER 4, HOW SWEET IT IS, PAGE 62
_____________________________________

Whereas, scientific data revealed that there was a problem with aspartame safety date and the United States Food and Drug Administration withdrew its approval; and

HERE IS THE ACTUAL BOARD OF INQUIRY REPORT REVOKING THE PETITION FOR ASPARTAME:
http://www.mpwhi.com/fda_petition1.doc
_______________________________________

Whereas, in 1975, the United States Food and Drug Administration initiated an investigation into Searle's laboratory practices and discovered fraud in scientific experiments as well as manipulated data giving favorable
results proving aspartame to be safe; and

IN JULY, 1975, FDA COMMISSIONER, DR ALEXANDER SCHMIDT APPOINTED A SPECIAL TASK FORCE TO LOOK AT 25 KEY STUDIES FOR THE DRUGS FLAGYL, ALDACTONE, NORPACE AND THE FOOD ADDITIVE ASPARTAME. ELEVEN OF THE PIVOTAL STUDIES EXAMINED INVOLVED ASPARTAME. ALL OF THE STUDIES WHETHER CONDUCTED AT G. D. SEARLE OR HAZLETON LABS WERE THE RESPONSIBILITY OF THE PATHOLOGY TOXICOLOGY DEPARTMENT AT G. D. SEARLE. (GROSS l987A,, PAGE 430 OF US SENATE 1987).

THE SPECIAL TASK FORCE WAS HEADED BY PHILIP BRODSKY, FDA'S LEAD INVESTIGATOR AND ASSISTED BY FDA TOXICOLOGIST, DR ADRIAN GROSS. G. D. SEARLE EXECUTIVES ADMITTED TO "PAYMENTS TO EMPLOYEES OF CERTAIN FOREIGN GOVERNMENTS TO OBTAIN SALES OF THEIR PRODUCTS." (SEARLE 1976) ON
JULY 10, 1975, SENATOR EDWARD KENNEDY CHAIRED A HEARING ON DRUG RELATED RESEARCH BEFORE THE SENATE SUBCOMMITTEE ON HEALTH OF THE COMMITTEE ON LABOR AND PUBLIC WELFARE (US SENATE 1975) PRELIMINARY REPORTS OF DISCREPANCIES DISCOVERED ABOUT G. D. SEARLE WERE DISCUSSED. THE FINDINGS OF THE FDA TASK FORCE WERE LATER PRESENTED AT FURTHER HEARINGS ON JANUARY 20, 1976 (US SENATE 1976 a) AND APRIL 8, 1976 (US SENATE 1976b). ON DECEMBER 8, 1975, STOCKHOLDERS FILED A CLASS ACTION LAWSUIT ALLEGING THAT G. D. SEARLE HAD CONCEALED INFORMATION FROM THE PUBLIC REGARDING THE NATURE AND QUALITY OF ANIMAL RESEARCH AT G. D. SEARLE IN VIOLATION OF THE SECURITIES AND EXCHANGE ACT (FARBER 1989, PAGE 48)

ON MARCH 24, 1976 THE FDA'S TASK FORCE REPORTS, "AT THE HEART OF THE FDA'S REGULATORY PROCESS IS ITS ABILITY TO RELY UPON THE INTEGRITY OF THE BASIC SAFETY DATA SUBMITTED BY SPONSORS OF REGULATED PRODUCTS. OUR INVESTIGATION
CLEARLY DEMONSTRATES THAT, IN THE G. D. SEARLE COMPANY, WE HAVE NO BASIS FOR SUCH RELIANCE NOW."

1 | 2 | 3 | 4 | 5 | 6